scPharmaceuticals SCPH
$ 3.27
-1.21%
Quarterly report 2024-Q3
added 11-13-2024
scPharmaceuticals Cash Flow 2011-2024 | SCPH
Annual Cash Flow scPharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-59.2 M | -34.6 M | -27.2 M | -27.7 M | -30.4 M | -28.8 M | -22.7 M | -15.5 M | - | - | - | - | - |
Depreciation & Amortization |
24 K | 37 K | 34 K | 34 K | 37 K | 38 K | 17 K | 5 K | - | - | - | - | - |
Accounts Payables |
4 M | 1.52 M | 544 K | 1.67 M | 1.14 M | 587 K | - | - | - | - | - | - | - |
Accounts Receivables |
4.49 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
8.84 M | 1.23 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow scPharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -17.7 M | - | - | - | -16.5 M | - | -22.7 M | -14.5 M | -7.37 M | - | -20.1 M | -14.9 M | -8.62 M | - | -18.5 M | -13.7 M | -7.74 M | - | -15.6 M | -10 M | -6.12 M | - | -23 M | -17.5 M | -9.07 M | - | -16.7 M | -10.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
5 K | 5 K | 6 K | - | 6 K | 6 K | 6 K | - | 10 K | 9 K | 9 K | - | 10 K | 8 K | 8 K | - | 8 K | 9 K | 8 K | - | 10 K | 9 K | 10 K | - | 10 K | 9 K | 10 K | - | 5 K | 1 K | 2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
5 M | 5.29 M | 2.71 M | 4 M | 3.37 M | 1.18 M | 1.63 M | 1.52 M | 996 K | 982 K | 445 K | 544 K | 447 K | 531 K | 753 K | 1.67 M | 1.67 M | 1.67 M | 1.67 M | 1.14 M | 1.14 M | 1.14 M | 1.14 M | 587 K | 587 K | 587 K | 587 K | 1.59 M | 1.59 M | 1.59 M | 1.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
9.22 M | 6.12 M | 5.77 M | 4.49 M | 4.18 M | 1.61 M | 3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
18.1 M | 15.3 M | 9.57 M | 8.84 M | 7.12 M | 5.83 M | 3.62 M | 1.23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency